Europe Acts to Address GLP-1 Drug Shortages
European drug authorities have actually provided suggestions to resolve continuous scarcities in glucagon-like peptide 1 (GLP-1) receptor agonists utilized to deal with type 2 diabetes and weight problems. These drugs consist of Ozempic (semaglutide), Saxenda (liraglutide), Trulicity (dulaglutide), and Victoza (liraglutide).Because 2022, GLP-1 receptor agonists have actually gotten appeal on social networks, where high profile influencers have actually backed them as wonder weight-loss drugs. Their off-label usage, especially by people who do not have diabetes or weight problems, is lowering the drugs' accessibility and positioning the public at threat for damage.Now, following the work of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), the European Medic...